-
Pharmeasy in talks with new investors for pre-IPO fund infusion
Pharmeasy was looking to raise nearly $200 million in primary capital from investors based in the US and Southeast Asia.
Pharmeasy was looking to raise nearly $200 million in primary capital from investors based in the US and Southeast Asia.
